CareDx Financials - Benzinga

CareDx Inc

CDNANASDAQ

Trade with Public

Trade with Public

$63.68

2.313.76%

À la clôture: Sep 25, 5:00 PM EST

$63.93

0.250.39%

Après les heures: 7:46 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

CareDx Financials

CareDx (CDNA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.23 by 60.87 percent. This is a 270 percent increase over earnings of $0.10 per share from the same

Benzinga Newsdesk

PRO
CareDx Raises FY2026 Sales Guidance from $447.000M-$465.000M to $490.000M-$500.000M vs $455.924M Est

CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000 million-$500.000 million vs $455.924 million estimate.

Benzinga Newsdesk

PRO
CareDx Raises FY2026 Sales Guidance from $420.000M-$444.000M to $447.000M-$465.000M vs $436.665M Est

CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $420.000 million-$444.000 million to $447.000 million-$465.000 million vs $436.665 million estimate.

Benzinga Newsdesk

PRO
CareDx Q1 Adj. EPS $0.34 Beats $0.13 Estimate, Sales $117.700M Beat $104.034M Estimate

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.13 by 161.54 percent. This is a 277.78 percent increase over earnings of $0.09 per share from the same

Benzinga Newsdesk

Earnings Scheduled For April 28, 2026

Benzinga Insights

CareDx Sharpens Focus On Core Testing Services

CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focusing on higher-growth precision testing and digital solutions.

Vandana Singh

© 2026 Benzinga | All Rights Reserved